1. Home
  2. SPPL vs HBIO Comparison

SPPL vs HBIO Comparison

Compare SPPL & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SPPL

SIMPPLE LTD.

N/A

Current Price

$3.25

Market Cap

19.0M

Sector

N/A

ML Signal

N/A

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$0.59

Market Cap

22.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPPL
HBIO
Founded
2016
1901
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
19.0M
22.1M
IPO Year
2023
2000

Fundamental Metrics

Financial Performance
Metric
SPPL
HBIO
Price
$3.25
$0.59
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$2.50
AVG Volume (30 Days)
5.2K
286.5K
Earning Date
04-08-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,591,508.00
$87,371,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.80
P/E Ratio
N/A
N/A
Revenue Growth
24.27
N/A
52 Week Low
$2.18
$0.28
52 Week High
$7.00
$1.49

Technical Indicators

Market Signals
Indicator
SPPL
HBIO
Relative Strength Index (RSI) 42.90 52.63
Support Level $2.97 $0.47
Resistance Level $3.42 $0.54
Average True Range (ATR) 0.23 0.04
MACD 0.05 0.00
Stochastic Oscillator 50.79 64.73

Price Performance

Historical Comparison
SPPL
HBIO

About SPPL SIMPPLE LTD.

Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Share on Social Networks: